文章摘要
张文元,帅文慧,曾宪有,蔡园觉,温晓飞.前列舒通联合坦洛新、左氧氟沙星治疗慢性骨盆疼痛综合征的疗效分析[J].井冈山大学自然版,2019,40(2):104-106
前列舒通联合坦洛新、左氧氟沙星治疗慢性骨盆疼痛综合征的疗效分析
CLINICAL EFFICACY OF QIANLIESHUTONG CAPSULE COMBINED WITH TASSULOSIN AND LEVOFLOXACIN IN TREATMENT OF CPPS
投稿时间:2018-11-12  修订日期:2018-12-26
DOI:10.3969/j.issn.1674-8085.2019.02.020
中文关键词: 慢性骨盆疼痛综合征  前列舒通胶囊  盐酸坦洛新缓释胶囊  左氧氟沙星胶囊
英文关键词: CPPS  qianlieshutong capsule  tamsulosin capsule  levofloxacin capsule
基金项目:江西省省卫计委科技支撑计划项目(2015A129)
作者单位
张文元 上海市东方医院吉安医院, 江西, 吉安 343000 
帅文慧 吉安市中心人民医院, 江西, 吉安 343000 
曾宪有 井冈山大学附属医院, 江西, 吉安 343000 
蔡园觉 上海市东方医院吉安医院, 江西, 吉安 343000 
温晓飞 上海市东方医院吉安医院, 江西, 吉安 343000 
摘要点击次数: 1536
全文下载次数: 2105
中文摘要:
      目的 探讨前列舒通胶囊联合盐酸坦洛新缓释胶囊、左氧氟沙星治疗慢性骨盆疼痛综合征的临床疗效。方法 160例慢性骨盆疼痛综合征患者随机分成两组,治疗组和对照组,每组80人,治疗组采用前列舒通胶囊2.5 g po tid,盐酸坦洛新缓释胶囊0.2 mg po qn,左氧氟沙星胶囊0.2 g po bid。对照组给予左氧氟沙星胶囊0.2 g po bid,4周为1个疗程,治疗时间为8周。记录治疗过程中的前列腺液常规和NIH-CPSI评分变化。结果 治疗组中80例治愈33例,治愈率41.3%,19例显效及有效,总有效率为65.0%;对照组中80例有17例治愈,治愈率21.25%,21例显效及有效,总有效率为47.0%。两组治愈率及总有效率相比,有明显差异,P<0.05,治疗组优于对照组。结论 前列舒通胶囊联合盐酸坦洛新缓释胶囊和左氧氟沙星治疗慢性骨盆疼痛综合征有效,值得临床应用。
英文摘要:
      Objective: To evaluate the clinical efficacy of qianlieshutong capsule combined with tamsulosin hydrochloride sustained-release capsules and levofloxacin in treatment of CPPS.Methods: 160 patients with CPPS were randomly divided into treatment group (n=80) and control group (n=80).Patients in treatment group were treated with qianlieshutong 2.5 g po bid,Tamsulosin 0.2 mg po qn,and levofloxasin 0.2g po bid.The course of treatment was 4 weeks in two groups.The clinical efficacy and NIH-CPSI between the two groups were compared.Results: The effective rate of the treatment group (65.0%) was significantly higher than that of the control group (47.0%,P<0.05).Conclusion: The clinical efficacy of qianlieshutong combined with tamsulosin and levofloxacin in treatment of CPPS is effective,which is worth of clinical application.
查看全文   查看/发表评论  下载PDF阅读器
关闭